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Abstract
Background: We aimed to estimate whether the macroscopic extent of gastric mucosal atrophy
is associated with a risk for esophageal squamous cell carcinoma using a case-control study in
Japanese subjects, a population known to have a high prevalence of CagA-positive H. pylori infection.
Methods:  Two hundred and fifty-three patients who were diagnosed as having esophageal
squamous cell carcinoma, and 253 sex- and age-matched controls were enrolled in the present
study. The macroscopic extent of gastric mucosal atrophy was evaluated based on the Kimura and
Takemoto Classification. A conditional logistic regression model with adjustment for potential
confounding factors was used to assess the associations.
Results: Body gastritis, defined endoscopically, was independently associated with an increased
risk for esophageal squamous cell carcinoma.
Conclusion:  Our findings suggest that macroscopic body gastritis may be a risk factor for
esophageal squamous cell carcinoma in Japan. Further studies are needed to confirm these findings.
Background
Esophageal cancer is the world's eighth most common
malignancy, affecting approximately 500,000 individuals
worldwide each year [1]. In Japan, the age-standardized
mortality rate of this cancer in 2000 was 10.4/100,000 for
men, approximately eight times that of women, and the
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sixth most frequent cause of death from cancer in Japa-
nese men [2]. There are two major histological types of
esophageal cancer, squamous cell carcinoma and adeno-
carcinoma, and their epidemiological features differ con-
siderably. Esophageal squamous cell carcinoma (ESCC)
has a predilection for black and Asian populations and,
worldwide, more than 80% of esophageal cancers are
squamous cell carcinomas. In contrast, esophageal aden-
ocarcinoma affects white populations predominantly. The
frequency of squamous cell carcinoma in Western coun-
tries has declined while there has been a dramatic rise in
the frequency of esophageal adenocarcinoma over the
past several decades [3,4]. Meanwhile more than 90% of
esophageal cancers in Japan have been squamous cell car-
cinoma, and no significant changes have been identified
[5].
Recently, a large population-based case-control study in
Sweden has demonstrated that cytotoxin-associated gene
A (CagA)-positive H. pylori infection is an increased risk
factor for ESCC, and gastric mucosal atrophy (GMA) may
be an important mediator of the positive association
between CagA seropositivity and ESCC [6]. These findings
suggest that GMA, induced CagA-positive Helicobacter
pylori (H. pylori) infection, is a risk factor for ESCC in Swe-
den. Iijima K et al. revealed that GMA, defined histologi-
cally or serologically, was associated with the risk for
ESCC and the risk seemed to increase with the progression
of GMA in Japanese subjects [7].
In the present study, we investigated whether the macro-
scopic extent of GMA is associated with a risk for ESCC
using a case-control study in Japanese subjects, a popula-
tion known to have a high prevalence of CagA-positive H.
pylori infection.
Methods
Patients
Two hundred and fifty-three consecutive patients who
were diagnosed as having ESCC at the Gastroenterology
Division of Yokohama City University Hospital from Jan-
uary 1997 to September 2008 were retrospectively
enrolled in the present study. Exclusion criteria were the
inability to obtain complete profiles from the subjects'
medical records; destruction of the esophagogastric junc-
tion (EGJ) by advanced ESCC; the inability to observe the
stomach on upper endoscopy because of esophageal sten-
osis due to advanced ESCC, or the subject had previously
undergone an upper digestive tract operation.
For each case, a control matched by sex and age group was
randomly selected from among patients who had under-
gone endoscopies as part of a health checkup during the
same period and who had no endoscopically-observed
localized lesions in the upper gastrointestinal tract. Exclu-
sion criteria for the controls were the inability to obtain
their complete profiles from their medical records; or they
had previously undergone an upper digestive tract opera-
tion.
Endoscopic findings
Our hospital operates a digital filing system for endo-
scopic images. All digital endoscopic images were inde-
pendently and retrospectively reviewed by two trained
endoscopists to investigate the endoscopic findings,
including GMA, hiatal hernia, erosive esophagitis, and
Barrett's epithelium. If there was any inconsistency in the
assessment of the digital endoscopic images, a final diag-
nosis was decided upon by a joint review of the digital
endoscopic images.
Gastric mucosal atrophy
The atrophic area of the stomach that can be visualized
endoscopically is known to extend from the antrum to the
body. Previously, Kimura and Takemoto endoscopically
divided GMA into six groups (C1, C2, C3, O1, O2, and
O3; C, closed; O, open) (Figure 1, 2) [8]. GMA has been
shown to progress from C1 to O3 successively, and this
classification correlates well with the histological features
of GMA [8]. Gastric acid secretion in patients with open-
type GMA has been reported to be lower than that in
patients with closed-type GMA [9]. In the present study,
we defined O2–3 cases as body gastritis.
Hiatal hernia
Hiatal hernia was diagnosed when the distance between
the gastroesophageal junction and the diaphragmatic hia-
tus was 2 cm or more.
Erosive esophagitis
Erosive esophagitis was diagnosed based on the Los Ange-
les Classification [10] and was divided into three groups:
none, mild (grades A and B), or severe (grades C and D).
Barrett's epithelium
The presence of Barrett's epithelium was diagnosed based
on the C & M Criteria [11]. According to the criteria, Bar-
rett's epithelium is defined as the macroscopic identifica-
tion, using a standard endoscopy exam, of abnormal
columnar esophageal epithelium suggestive of a colum-
nar-lined distal esophagus. The length of Barrett's epithe-
lium is measured (in centimeters) using the
circumferential extent (the C extent) and the maximum
extent (the M extent) above the gastroesophageal junc-
tion, identified as the proximal margin of the gastric
mucosal folds [11].
Patients profiles
Complete patient information at the time of the initial
diagnosis, including age, sex, body mass index (BMI), reg-BMC Gastroenterology 2009, 9:34 http://www.biomedcentral.com/1471-230X/9/34
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ular drinking and smoking habits, was obtained from
each patient's medical records.
Ethics
The study was conducted in accordance with the Declara-
tion of Helsinki. The study protocol was approved by the
Ethics Committee of Yokohama City University Hospital.
Statistical analysis
In a case control study, distribution of the demographic
characteristics and related factors were compared between
ESCC patients and controls. The statistical analysis
included a Chi-square test or a Fisher exact test to compare
percentages and a Mann-Whitney U test to compare con-
tinuous data. Various risk factors were also evaluated
simultaneously using logistic regression. The level of sig-
nificance was defined as p < 0.05. All statistical analyses
were performed using Stat View software (SAS Institute,
Cary, N.C.).
Results
The comparison of patient profiles and endoscopic find-
ings between the ESCC and the sex- and age-matched con-
trol groups is shown in Table 1. The majority of subjects
were male, and median (range) age was 65 (38–86) years
old both in the ESCC and control groups. The BMI in
ESCC cases was significantly lower than in controls, sug-
gests decreasing dietary intake caused by dysphagia and
appetite loss in advanced ESCC subjects. The prevalences
of current regular drinking and current smoking habits,
and open-type 2–3 GMA were significantly higher in
ESCC cases than in controls. There was no significant dif-
ference in the frequency of hiatal hernia between cases
and controls. The rates of erosive esophagitis and Barrett's
epithelium, as complications of gastroesophageal reflux
disease (GERD), were significantly lower in ESCC cases
than in controls.
Multiple logistic regression analysis of the clinical factors
associated with ESCC is demonstrated in Table 2. After
adjustment for clinical factors, including BMI, current reg-
ular drinking and smoking habits, open-type 2–3 GMA
had an independently significant positive association
with the prevalence of ESCC, which strongly suggests that
macroscopic body gastritis was an independent risk factor
for ESCC. Erosive esophagitis showed an independently
significant inverse association with ESCC, while Barrett's
epithelium had no such association.
Classification of an endoscopically evident atrophic pattern Figure 1
Classification of an endoscopically evident atrophic 
pattern. The atrophic border is the boundary between the 
pyloric and fundic gland territories, which is endoscopically 
recognized by discriminating differences in the color and 
height of the gastric mucosa. Cases of closed-type GMA have 
an atrophic boundary between the fundic mucosa and the 
pyloric mucosa in the antrum or lesser curvature of the gas-
tric body. Cases of open-type GMA have an atrophic bound-
ary in the lateral wall or greater curvature of the gastric body 
[8]. C, closed; O, open.
An endoscopic image of open-type GMA Figure 2
An endoscopic image of open-type GMA. The atrophic 
border, determined by discriminating differences in the color 
and height of the gastric mucosa, is recognized in the greater 
curvature of the angular portion. (White arrows indicate the 
atrophic border).BMC Gastroenterology 2009, 9:34 http://www.biomedcentral.com/1471-230X/9/34
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Discussion and conclusion
GMA induced by H. pylori infection may form a milieu
that favors bacterial overgrowth which, in turn, may
increase endogenous nitrosation [12,13], which was sta-
tistically significantly correlated with mortality from
esophageal cancer, predominantly ESCC, in a Chinese
ecologic study [14]. Thus, H. pylori infection may increase
the risk of ESCC through abolishment of normal gastric
secretion. However, there have been only a few studies
regarding the relation between H. pylori infection and the
risk of ESCC, and this issues remains controversial [6,15-
17]. Some studies, using serum IgG antibodies against H.
pylori as the only marker for the infection, demonstrated
no or an inverse association between infection and ESCC
[6,15-17]. On the other hand, one of these studies, using
serum antibodies against the CagA of H. pylori or a combi-
nation of H. pylori IgG antibodies and CagA antibodies to
define the infection, revealed a positive correlation
between the two factors, and additionally found that
GMA, assessed by serum levels of pepsinogen, was associ-
ated with an increased risk for ESCC [6]. There may have
been an underestimation of the infection rate in the ESCC
patients in these studies, in whom extensive GMA with
spontaneous eradication of H. pylori might have occurred
due to the hostile gastric condition to the bacterium
[18,19].
The prevalence of H. pylori infection is much higher in
Japan than Western countries [20]. Moreover, most strains
of H. pylori isolated from Japanese patients are cagA-posi-
tive [21], which induces more severe inflammation and
atrophy in the gastric mucosa, leading to changes in gas-
tric acid secretion [22,23]. Several investigators have
shown that H. pylori infection increases acid secretion in
duodenal ulcers with antral-dominant gastritis [24,25],
while it decreases acid secretion in body gastritis [26,27].
Furthermore, it has been confirmed that increased or
decreased acid secretion is restored following the eradica-
tion of H. pylori [24-27], strongly supporting the premise
that H. pylori infection alters the function of gastric acid
secretion. In Japan, the incidence of GMA extending to the
gastric body increases with age, resulting in a marked
reduction of acid secretion in the elderly [27,28]. Iijima K
et al. revealed that GMA, defined histologically or serolog-
ically, was associated with the risk for ESCC and the risk
seemed to increase with the progression of GMA in Japa-
Table 1: Comparison of Characteristics between ESCC cases and controls (P value: Mann-Whitney U test; *chi square test; **Fisher's 
exact test).
ESCC cases
(N = 253)
Controls
(N = 253)
p-value
Patients profiles
Male/Female 225/28 225/28 >0.9999
Age (median; range) 65; 38–86 65; 38–86 >0.9999
BMI (median; range) 20.9; 14.8–30.8 22.8; 14.5–33.1 <0.0001
Current regular drinker 210 (83.0%) 142 (56.1%) <0.0001*
Current smoker
Endoscopic findings
205 (81.0%) 133 (52.6%) <0.0001*
GMA Open-type 2, 3 164 (64.8%) 127 (50.2%) 0.0009*
Hiatal hernia 60 (23.7%) 74 (29.2%) 0.1584*
Erosive esophagitis
Total (LA-A to D) 13 (5.1%) 64 (25.3%) <0.0001*
Mild (LA-A, B) 12 (4.7%) 59 (23.3%) <0.0001*
Severe (LA-C, D) 1 (0.4%) 5 (2.0%) 0.2160**
Barrett's epithelium 80 (31.6) 114 (45.1%) 0.0019*
BMI = body mass index; GMA = gastric mucosal atrophy
Table 2: Multiple logistic regression analysis of clinical factors associated with ESCC.
Clinical factors Odds ratio 95% confidence interval P-value
Body mass index 0.870 0.813–0.930 <0.0001
Regular drinking habit 3.228 2.028–5.138 <0.0001
Smoking habit 3.231 2.062–5.063 <0.0001
GMA 1.572 1.035–2.386 0.0339
Hernia 0.928 0.575–1.498 0.7608
Erosive esophagitis 0.178 0.089–0.359 <0.0001
Barrett's epithelium 0.671 0.434–1.039 0.0734BMC Gastroenterology 2009, 9:34 http://www.biomedcentral.com/1471-230X/9/34
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nese subjects [7], suggesting that GMA may be an impor-
tant mediator of the association between CagA-positive H.
pylori and ESCC. This finding is consistent with a recent
population-based case-control study from Sweden [6]. We
did not unfortunately perform histological and serologi-
cal diagnosis of GMA in the present study, in place of
which the endoscopic diagnosis of body gastritis was
adopted. In our study, endoscopic body gastritis, defined
by open-type 2–3 GMA, was a independent risk factor for
ESCC among Japanese subjects after adjustment for con-
ventional risk factors, such as current regular drinking and
smoking habits. This finding was consistent with the
aforesaid subgroup analysis [6,7].
According to the univariate analysis, both erosive
esophagitis and Barrett's epithelium, as complications of
GERD, had an inverse-association with ESCC. Body gastri-
tis, considered as a negatively associated factor of GERD,
may be an important mediator of this association. But,
even after adjustment for GMA Open-type 2–3, erosive
esophagitis was independently significantly associated
with ESCC. Advanced ESCC may play a partly suppressive
role in the development of GERD through decreasing the
dietary intake caused by dysphagia and appetite loss. It
might be necessary to set up the ESCC cases, consisting
only of superficial ESCC, for close assessment of extensive
GMA as an important mediator of the correlation between
ESCC and GERD complications. Our study has one poten-
tial limitation that may need to be considered, which is
the difficulty in the selection of appropriate clinical con-
trols, although this always occurs in case-control design
studies. In the present study, we selected control subjects
from among our outpatients who had undergone endo-
scopies for a health checkup during the same period and
who had no endoscopically-identified localized lesions in
the upper gastrointestinal tract. Nonetheless, the preva-
lences of endoscopic findings, including GMA, erosive
esophagitis and Barrett's epithelium, in the controls were
similar to those in previous reports with a Japanese popu-
lation [29,30]. Hence, a bias in the selection of controls is
unlikely, although a prospective cohort study is required
to resolve this issue. In conclusion, body gastritis, diag-
nosed endoscopically, is an independent risk factor for
ESCC in Japanese subjects. The identification of a high
risk group for ESCC by macroscopic body gastritis, as well
as heavy smoking and drinking, may be helpful in devel-
oping more efficient screening programs. Further studies
are needed to confirm the causal relationship between
GMA and the development of ESCC.
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